Atlas Trials

A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901

Clinical trial NCT01526473 · COMPLETED

Trial details

NCT number
NCT01526473
Sponsor
H. Kim Lyerly
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2+ Cancer
Start date
2012-02-01
Primary completion
2016-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.